Processa Pharmaceuticals, Inc. (PCSA) financial statements (2023 and earlier)

Company profile

Business Address 7380 COCA COLA DRIVE
HANOVER, MD 21076
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,49815,4166921,7412,8473
Cash and cash equivalents16,49815,4166921,7412,8473
Receivables 155 2263 
Prepaid expense   25841 
Other undisclosed current assets1,830632316   
Total current assets:18,32716,2031,0072,0202,9523
Noncurrent Assets
Property, plant and equipment 09172619
Intangible assets, net (including goodwill)   10,438  
Intangible assets, net (excluding goodwill)   10,438  
Deposits noncurrent assets   6  
Other noncurrent assets8,1369,0119,867 6 
Other undisclosed noncurrent assets     (19)
Total noncurrent assets:8,1369,0129,87610,46131 
TOTAL ASSETS:26,46425,21410,88312,4812,9833
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities498546311416151742
Accounts payable2193217629251166
Accrued liabilities27922521310364135
Taxes payable     0
Interest and dividends payable 1222036441
Debt 1188802302,4491,382
Due to related parties2700 0 
Other undisclosed current liabilities471487   230
Total current liabilities:9711,2211,1926462,6002,354
Noncurrent Liabilities
Long-term debt and lease obligation778147   
Operating lease, liability778147
Liabilities, other than long-term debt 5311,5322,13410 
Accounts payable and accrued liabilities    10 
Deferred tax liabilities, net2,134  
Deferred income tax liabilities 5311,532
Other undisclosed noncurrent liabilities(7)445    
Total noncurrent liabilities:71,0541,6792,13410 
Total liabilities:9782,2752,8712,7802,6102,354
Stockholders' equity
Stockholders' equity attributable to parent, including:25,48522,9398,0139,701373(2,351)
Preferred stock     0
Common stock211441
Common stock, value, subscriptions   1,800  
Additional paid in capital62,30748,33418,99419,1214,22914,329
Accumulated deficit(36,823)(25,396)(10,982)(7,624)(3,859)(15,255)
Other undisclosed stockholders' equity attributable to parent  0(3,600) (1,426)
Total stockholders' equity:25,48522,9398,0139,701373(2,351)
TOTAL LIABILITIES AND EQUITY:26,46425,21410,88312,4812,9833

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues    55
Revenue, net 5
Other income    5 
Gross profit:    55
Operating expenses(4,689)(6,437)(3,935)(4,525)(1,802)(77)
Other operating expense, net     (266)
Other undisclosed operating loss(7,445)(8,700)  (5) 
Operating loss:(12,134)(15,137)(3,935)(4,525)(1,802)(337)
Nonoperating income
(Investment Income, Nonoperating)
12312185 
Interest and debt expense(0)(281)(37)(161)(59)(241)
Loss from continuing operations before equity method investments, income taxes:(12,122)(15,415)(3,961)(4,668)(1,856)(578)
Other undisclosed income from continuing operations before income taxes164    241
Loss from continuing operations before income taxes:(11,958)(15,415)(3,961)(4,668)(1,856)(337)
Income tax benefit5311,001603903  
Loss from continuing operations:(11,428)(14,414)(3,358)(3,765)(1,856)(337)
Income from discontinued operations     1
Net loss:(11,428)(14,414)(3,358)(3,765)(1,856)(336)
Net income attributable to noncontrolling interest     43
Other undisclosed net loss attributable to parent     (43)
Net loss attributable to parent:(11,428)(14,414)(3,358)(3,765)(1,856)(336)
Other undisclosed net loss available to common stockholders, basic (56)(507)  (43)
Net loss available to common stockholders, diluted:(11,428)(14,469)(3,865)(3,765)(1,856)(379)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(11,428)(14,414)(3,358)(3,765)(1,856)(336)
Comprehensive loss, net of tax, attributable to parent:(11,428)(14,414)(3,358)(3,765)(1,856)(336)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: